17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

Clinical trial NCT00088868 · COMPLETED

Trial details

NCT number: NCT00088868
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2004-06-01
Primary completion: 2010-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.